(Q44178390)

30 November 2017

title

Discontinued drugs in 2012: oncology drugs (English)

1 reference

30 November 2017

Robert Williams

1

1 reference

30 November 2017

language of work or name

English

0 references

publication date

8 October 2013

1 reference

Expert Opinion on Investigational Drugs

30 November 2017

published in

1 reference

30 November 2017

volume

22

1 reference

30 November 2017

issue

12

1 reference

30 November 2017

page(s)

1627-1644

1 reference

Discontinued drugs in 2011: oncology drugs

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.847088

Envisioning the future of early anticancer drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.847088

How much gets there and what does it do?: The need for better pharmacokinetic and pharmacodynamic endpoints in contemporary drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.847088

Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.847088

21 January 2018

2012 FDA drug approvals

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.847088

Gatekeepers and Enablers: How Drug Regulators Respond to a Challenging and Changing Environment by Moving Toward a Proactive Attitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.847088

10.1517/13543784.2013.847088

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference